Company Filing History:
Years Active: 2016
Title: Paul Dicarlo: Innovator in Drug-Delivery Technology
Introduction
Paul Dicarlo, based in Middleboro, Massachusetts, is an accomplished inventor known for his innovative contributions to medical technology. With one patent to his name, he has made significant strides in developing devices that enhance medical procedures, particularly in the area of drug delivery.
Latest Patents
Paul Dicarlo holds a patent for a drug-delivery device designed for use with an ablation device. This device includes a body that can be attached to a handle of an ablation device, featuring a shaft portion that defines a passageway. The design encompasses a delivery lumen intended to facilitate drug delivery to tissue. Notably, the body consists of a proximal portion, a distal portion, and a contoured portion that fits with the handle of the ablation device. The shaft includes both a proximal end and a distal end, allowing the delivery lumen to move slideably within the passageway. The integration of a knob member coupled to the proximal portion of the delivery lumen further enhances its functionality in medical settings.
Career Highlights
Paul is currently associated with Covidien LP, a company that specializes in medical devices and currently operates under the banner of Medtronic after its acquisition. His work at Covidien LP has positioned him at the forefront of innovation in healthcare technology, advancing how medical procedures are performed.
Collaborations
Throughout his career, Paul has had the opportunity to work alongside talented colleagues such as Rachit Ohri and Lan Pham. Their collaboration has likely contributed to the innovative spirit found within their projects at Covidien LP, ultimately enhancing the quality and effectiveness of medical devices.
Conclusion
In summary, Paul Dicarlo is a noteworthy inventor whose developments in drug-delivery devices are advancing medical procedures. His patent reflects a commitment to innovation and collaboration within the medical technology sector, and his contributions are poised to make a lasting impact on healthcare.